PK Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Patients Undergoing Vitrectomy
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics (PK) of dexamethasone phosphate
ophthalmic solution delivered via the EyeGate® II Drug Delivery System (EGDS) in patients
undergoing vitrectomy for macular hole repair or epiretinal membrane peeling